Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Apr 4;10(4):e2425.
doi: 10.7759/cureus.2425.

Mesalamine Associated Bradycardia

Affiliations
Case Reports

Mesalamine Associated Bradycardia

Michael Krzyzak et al. Cureus. .

Abstract

A 38-year-old female presented with an acute flare of ulcerative colitis. She was started on prednisone and mesalamine. Within 24 hours of initiating mesalamine, she developed sinus bradycardia. After holding mesalamine, the heart rate returned to normal within five days. Our case illustrates the third described case, to our knowledge, of severe sinus bradycardia secondary to mesalamine.

Keywords: bradycardia; drug side effects; ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Computed Tomography of the Abdomen
Circumferential wall thickening and mucosal hyperenhancement of the sigmoid colon and the rectum with surrounding inflammatory changes and several subcentimeter pericolonic lymph nodes (blue arrow).
Figure 2
Figure 2. Electrocardiogram Showing Sinus Bradycardia

References

    1. Sulphasalazine and salicylazosulphadimidine in ulcerative colitis. Baron JH, Connell AM, Lennard-Jones JE, Jones FA. Lancet. 1962;1:1094–1096. - PubMed
    1. Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Miner P Jr, Hanauer S, Robinson M, Schwartz J, Arora S. Dig Dis Sci. 1995;40:296–304. - PubMed
    1. Severe symptomatic sinus bradycardia associated with mesalamine use. Asirvatham S, Sebastian C, Thadani U. Am J Gastroenterol. 1998;93:470–471. - PubMed
    1. An experiment to determine the active therapeutic moiety of sulphasalazine. Azad Khan AK, Piris J, Truelove SC. Lancet. 1977;310:892–895. - PubMed
    1. Lichtenstein GR, Blonski W, Mudireddy PRS. New York: Springer; 2014. Atsushi: Medical Therapy of Ulcerative Colitis.

Publication types

LinkOut - more resources